Clinical Trial Update: Using Mirabegron to Increase BP in Patients With POTS [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating mirabegron to increase blood pressure in patients with Postural Orthostatic Tachycardia Syndrome has completed and results have been po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Orthostatic Intolerance
• Postural Orthostatic Tachycardia Syndrome
• Syncope

Drugs mentioned

• Mirabegron (mirabegron)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Postural Orthostatic Tachycardia Syndrome, Chronic Orthostatic Intolerance | Phase 2 | Status: COMPLETED | Results posted: 2026-04-08